Sugano M, Makino N, Sawada S, Otsuka S, Watanabe M, Okamoto H, Kamada M, Mizushima A
Department of Bioclimatology and Medicine, Medical Institute of Bioregulation, Kyushu University, 4546 Tsurumihara, Beppu, Oita 874, Japan.
J Biol Chem. 1998 Feb 27;273(9):5033-6. doi: 10.1074/jbc.273.9.5033.
Cholesteryl ester transfer protein (CETP) is the enzyme that facilitates the transfer of cholesteryl ester from high density lipoprotein (HDL) to apolipoprotein B (apoB)-containing lipoproteins. However, the exact role of CETP in the development of atherosclerosis has not been determined. In the present study, we examined the effect of the suppression of increased plasma CETP by intravenous injection with antisense oligodeoxynucleotides (ODNs) against CETP targeted to the liver on the development of atherosclerosis in rabbits fed a cholesterol diet. The ODNs against rabbit CETP were coupled to asialoglycoprotein (ASOR) carrier molecules, which serve as an important method to regulate liver gene expression. Twenty-two male Japanese White rabbits were used in the experiment. Eighteen animals were fed a standard rabbit chow supplemented with 0.3% cholesterol throughout the experiment for 16 weeks. At 8 weeks, they were divided into three groups (six animals in each group), among which the plasma total and HDL cholesterol concentrations did not significantly change. The control group received nothing, the sense group were injected with the sense ODNs complex, and the antisense group were injected with the antisense ODNs complex, respectively, for subsequent 8 weeks. ASOR. poly(L-lysine) ODNs complex were injected via the ear veins twice a week. Four animals were fed a standard rabbit diet for 16 weeks. The total cholesterol concentrations and the CETP mass in the animals injected with antisense ODNs were all significantly decreased in 12 and 16 weeks compared with those injected with sense ODNs and the control animals. The HDL cholesterol concentrations measured by the precipitation assay did not significantly change among the groups fed a cholesterol diet, and triglyceride concentrations did not significantly change in the four groups. However, at the end of the study, when the HDL cholesterol concentrations were measured after the isolation by ultracentrifugation and a column chromotography, they were significantly higher in the animals injected with antisense ODNs than in the animals injected with sense ODNs and in the control animals. A reduction of CETP mRNA and an increase of LDL receptor mRNA in the liver were observed in the animals injected with antisense ODNs compared with those injected with sense ODNs and the control animals. Aortic cholesterol contents and the aortic percentage lesion to total surface area were significantly lower in the animals injected with antisense ODNs than in the animals injected with sense ODNs and in the control animals. These findings showed for the first time that suppression of increased plasma CETP by the injection with antisense ODNs against CETP coupled to ASOR carrier molecules targeted to the liver could thus inhibit the atherosclerosis possibly by decreasing the plasma LDL + very low density lipoprotein (VLDL) cholesterol in cholesterol-fed rabbits.
胆固醇酯转运蛋白(CETP)是一种促进胆固醇酯从高密度脂蛋白(HDL)转移至含载脂蛋白B(apoB)的脂蛋白的酶。然而,CETP在动脉粥样硬化发展过程中的确切作用尚未明确。在本研究中,我们通过静脉注射针对肝脏的CETP反义寡脱氧核苷酸(ODNs)来抑制血浆中升高的CETP,从而研究其对喂食高胆固醇饮食的家兔动脉粥样硬化发展的影响。针对兔CETP的ODNs与去唾液酸糖蛋白(ASOR)载体分子偶联,这是调节肝脏基因表达的一种重要方法。本实验使用了22只雄性日本白兔。18只动物在整个16周的实验过程中喂食添加了0.3%胆固醇的标准兔饲料。在第8周时,将它们分为三组(每组6只动物),此时血浆总胆固醇和HDL胆固醇浓度无显著变化。对照组不做处理,正义组注射正义ODNs复合物,反义组注射反义ODNs复合物,后续8周持续进行。ASOR - 聚(L - 赖氨酸)ODNs复合物通过耳静脉每周注射两次。另外4只动物喂食标准兔饲料16周。与注射正义ODNs的动物及对照动物相比,注射反义ODNs的动物在第12周和16周时总胆固醇浓度和CETP含量均显著降低。通过沉淀法测定,喂食胆固醇饮食的各组之间HDL胆固醇浓度无显著变化,四组动物的甘油三酯浓度也无显著变化。然而,在研究结束时,通过超速离心和柱色谱法分离后测量HDL胆固醇浓度时,注射反义ODNs的动物的HDL胆固醇浓度显著高于注射正义ODNs的动物和对照动物。与注射正义ODNs的动物及对照动物相比,注射反义ODNs的动物肝脏中CETP mRNA减少,LDL受体mRNA增加。注射反义ODNs的动物的主动脉胆固醇含量和主动脉病变面积占总表面积的百分比显著低于注射正义ODNs的动物和对照动物。这些发现首次表明,通过静脉注射与靶向肝脏的ASOR载体分子偶联的CETP反义ODNs来抑制血浆中升高的CETP,可能通过降低喂食胆固醇的家兔血浆低密度脂蛋白 + 极低密度脂蛋白(VLDL)胆固醇来抑制动脉粥样硬化。